Oral semaglutide showed superior reductions in blood sugar vs Jardiance® and non-inferior blood sugar reductions vs Victoza® in adults with type 2 diabetes at 26 weeks

Media:

Katrine Sperling

+45 4442 6718

[email protected]

Michael Bachner (US)

+1 609 664 7308

[email protected]

Investors:

Peter Hugreffe Ankersen

+45 3075 9085

[email protected]

Valdemar Borum Svarrer

+45 3079 0301

[email protected]

Ann Søndermølle Rendbæk

+45 3075 2253

[email protected]

Kristoffer Due Berg (US)

+1 609 235 2989

[email protected]